Precision Medicine Market - Forecast(2022 - 2027)



Precision Medicine Market size is $113.76Bn in 2019, growing at a CAGR of 13.2% during the forecast period 2020-2025. Precision medicine is also called personalized medicine or individualized medicine is an approach that protects health and treat diseases taking into account an individual variability in genes, environment and lifestyle for every individual. It includes the use of system biology to determine the reason for an individual patient's illness at the molecular diagnosis level. It uses advanced technologies in clinical and basic research to develop therapeutics that selectively target panomic analysis and kill cancer cells. It allows doctors and researchers to predict more accurately which treatment and prevention strategies should be adopted for a particular disease or condition.



Report Coverage
The report: “Precision Medicine Market – Forecast (2020-2025)”, by IndustryARC covers an in-depth analysis of the following segments of the Precision Medicine Market.


By Indication: Respiratory Disorders, Oncology, Immunology, Central Nervous System (CNS), Infectious Diseases and Others.
By Technology: Drug Discovery, Gene Sequencing, Bioinformatics, Big Data Analysis and Others.
By Drugs Type: Mepolizumab, Alectinib, Aripiprazole Lauroxil and Others.
By End User: Hospitals/Clinics, Pharmaceuticals, Diagnostic Centers and Others
By Geography: North America, Europe, Asia-Pacific and Rest of the World


Key Takeaways
Increasing awareness amongst people for early treatment of disease is set to propel the growth of the market.
Increasing prevalence of cancer is the driving factors for the growth of Precision Medicine market.
Increased geriatric population with modernized routine disorders aiding growth towards the market.
Europe region is estimated to record the fastest growth rate during the forecast period 2020-2025.


By Indication - Segment Analysis
In 2019, Oncology segment dominated the Precision Medicine Market in terms of revenue is estimated to grow at a CAGR of 11.2%. Precision medicine helps in the treatment of cancer patients by including surgery, chemotherapy, radiation therapy and immunotherapy depending on the cancerous tumor cell size. Precision medicine gives the information about genetic changes of tumor in individuals which helps in deciding the treatment procedures. Mepolizumab is an effective medicine for breast and lung cancer abetting towards the market’s growth.


Geography - Segment Analysis
In 2019, the North America region dominated Precision Medicine Market in terms of revenue with a market share of 39% owing towards owing to the presence of established payers and an increase in the number of cancer patients in the region. This growth can be attributed towards the increasing research & development initiatives and government support for the improvement of the healthcare sector. U.S holds the biggest market for central nervous system treatment, followed by Canada in North America. The increasing awareness about the health and availability of new treatment methods drives the market in this region is key factors in the growth of the Precision Medicine market. Europe is estimated to record the fastest growth rate during the forecast period 2020-2025.


Drivers – Precision Medicine Market


Increasing In The Prevalence Of Cancer
According to World Health Organization (WHO), in 2018, 9.6 million people worldwide died of cancer. Cancer is said to be one of the leading causes of death globally. The increasing incidence of cancer has increased the need for cancer therapies is rising with the increasing number of cancer cases and deaths caused by genetic cancerous tumors. Government focusing on the drug development for the reduction of cancer cases is the other major factor driving growth. Increasing healthcare expenditure by various countries is also contributing to the market growth.



Challenges – Precision Medicine Market


Cost and Time Associated with Development
High cost is associated with the development and manufacture of genomic precision drugs. The long period of research and development and also the clinical trials take long time. Technologies such as sequencing large amounts of DNA are expensive to carry out (although the cost of sequencing is decreasing quickly) hampering the market’s growth. Strict regulations and patent expiry of various drugs may act key restraining factors for the Precision Medicine Market.


Precision Medicine Industry Outlook
Product Launches was the key strategy of the players in the Precision Medicine Industry. Precision Medicine top 10 companies include Medtronic PLC, Pfizer Inc., Novartis AG, Qiagen NV, Teva Pharmaceuticals, AstraZeneca plc., Takeda Pharmaceutical Company Ltd., Merck& Co. Inc., Teijin Pharma Ltd. and Thermo Fisher Scientific Inc.



Acquisitions/Product Launches
In January 2020, Merck& Co. Inc acquired ArQule, Inc. This acquisition helped the company in increasing the oncology product production.
In January 2019, Takeda Pharmaceutical Company Ltd acquired Shire plc. This acquisition helped the company in accelerating transformation journey to deliver highly-innovative medicines to patients around the world with expanded scale and geographical footprint.
Location: United States

Comments

Post a Comment

Popular posts from this blog

Narcolepsy Market - Forecast(2022 - 2027)

  Narcolepsy Market size is estimated to be $2.68 billion in 2019, growing at a CAGR of 10.4% during the forecast period 2020-2025.Increasing obese population and rising prevalence of narcolepsy is a major factor driving the narcolepsy market during the forecast period 2020-2025.Futhermore, narcolepsy is a lifelong nervous system disorder that effect a person quality of life. Moreover, according to the Narcolepsy Network narcolepsy affected an estimated 1 in every 2000 people in the U.S. That’s 2000,000 Americans and approximately 3 million worldwide. Furthermore, people suffering from narcolepsy frequently enter into cataplexy and REM sleep within every 15 minutes of falling asleep, thereby driving the demand of proper narcolepsy treatment which in turn is boosting the narcolepsy market. In addition sleep apnea symptoms are similar to narcolepsy and patients go through excessive daytime sleepiness (EDS) thereby raising the demand of narcolepsy treatment. Request Sample Report Coverag
Read more

Postmenopausal Hormone Therapy Market Forecast (2022-2027)

Image
  Postmenopausal Hormone Therapy Market size is estimated   to reach $46.5 billion   by 2027, growing   at a CAGR of 5.1%   during the forecast period 2022-2027. Postmenopausal Hormone Therapy includes medicines covering female hormones to take the place of the once the body no longer makes subsequent to menopause and is occasionally utilized to treat typical menopausal symptoms, inclusive of hot flashes and vaginal discomfort. Hormone therapy has also been confirmed to avert bone loss and decrease fractures in postmenopausal women. Atrophic vaginitis is normally associated with menopause and the related depleted levels of estrogen. Bazedoxifene is a novel SERM (Selective Estrogen Receptor Modulator) established by Wyeth Pharmaceuticals that is presently in phase III clinical trials for the avoidance and treatment of postmenopausal osteoporosis. Phytoestrogens are organic constituents from plants that bind to estrogen receptors in the body. Download Report Sample The proliferating pop
Read more

Mechanical Ventilation & Accessories Market - Forecast (2023 - 2028)

  Mechanical ventilator,  sometimes also known as ventilator, breathing machine or respirator, is a device which is used by healthcare institutions and hospitals in the management of patient’s breathing problems. Usage of mechanical ventilation process is the last choice for a patient who is suffering from breathing problems and cannot maintain adequate oxygenation to maintain life. Mechanical ventilation process is mainly used in the treatment of chronic obstructive pulmonary disease (COPD), apnea, acute lung injury and hypoxemia.  Globally, increasing incidences of chronic diseases, such as chronic obstructive pulmonary disease (COPD), asthma, bronchitis, and other lunch disorders are expected to remain key growth drivers for the mechanical ventilation & accessories market during the period of study. Download Report Sample Geographically, North America dominated the mechanical ventilation & accessories market driven by world class healthcare infrastructure with sophisticated
Read more